MESC — Lophos Holdings Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Lophos Holdings, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -0.33 | -0.988 | -1.28 |
Depreciation | |||
Non-Cash Items | -0.02 | 0.178 | 0.468 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 0.263 | -0.017 | -0.053 |
Change in Accounts Receivable | |||
Change in Prepaid Expenses | |||
Change in Accrued Expenses | |||
Change in Payable / Accrued Expenses | |||
Cash from Operating Activities | -0.082 | -0.787 | -0.833 |
Capital Expenditures | -0.435 | -0.028 | -0.097 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | 0.826 | 0 | -0.013 |
Acquisition of Business | |||
Sale of Business | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 0.392 | -0.028 | -0.11 |
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 0.691 | -0.046 | 0.808 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 1 | -0.861 | -0.136 |